A 74-year-old male with metastatic prostate cancer is taking subcutaneous injections of leuprorelin on a monthly basis | Medibuddy
1st April 2022

A 74-year-old male with metastatic prostate cancer is taking subcutaneous injections of leuprorelin on a monthly basis

A 74-year-old male with metastatic prostate cancer is taking subcutaneous injections of leuprorelin on a monthly basis. What is the best way to describe the mechanism of action of leuprorelin?

Select the SINGLE most appropriate option. Select ONE option only.

Mobile app screenshots

Take your subscriptions with you

Our mobile app allows you to access your interview and exam question banks wherever you are.